Literature DB >> 26876001

Association of anti-RNA polymerase III antibody and silicone breast implants in patients with systemic sclerosis.

Ryosuke Saigusa1, Yoshihide Asano1, Kouki Nakamura1, Takashi Yamashita1, Yohei Ichimura1, Takehiro Takahashi1, Tetsuo Toyama1, Takashi Taniguchi1, Ayumi Yoshizaki1, Miki Miyazaki1, Zenshiro Tamaki1, Shinichi Sato1.   

Abstract

Systemic sclerosis (SSc) is believed to be caused by a complex interplay between genetic factors and environmental influences. Although silicone has been considered to be a candidate of environmental agents, clinical data presented so far fail to show a significant association between silicone breast implant (SBI) and the development of SSc. Because we recently experienced two consecutive SSc patients with anti-RNA polymerase III (RNAP III) antibody who underwent SBI, we here investigated the association of SBI history with the development of SSc positive for anti-RNAP III antibody. Among 262 Japanese SSc patients, of note, the frequency of SBI history was significantly higher in the anti-RNAP III antibody group (16.0% [4/25]) than in the anti-topoisomerase I antibody group (0% [0/87], P < 0.005) and in the anticentromere antibody group (1.2% [2/150], P < 0.005). These results suggest that SBI could influence the development of SSc in a certain subset of patients with anti-RNAP III antibody.
© 2016 Japanese Dermatological Association.

Entities:  

Keywords:  anti-RNA polymerase III antibody; chronic inflammation; environmental factor; silicone breast implant; systemic sclerosis

Mesh:

Substances:

Year:  2016        PMID: 26876001     DOI: 10.1111/1346-8138.13292

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  7 in total

Review 1.  Pathogenesis of systemic sclerosis-current concept and emerging treatments.

Authors:  Masutaka Furue; Chikage Mitoma; Hiroki Mitoma; Gaku Tsuji; Takahito Chiba; Takeshi Nakahara; Hiroshi Uchi; Takafumi Kadono
Journal:  Immunol Res       Date:  2017-08       Impact factor: 2.829

Review 2.  Systemic sclerosis with anti-RNA polymerase III positivity following silicone breast implant rupture: possible role of B-cell depletion and implant removal in the treatment.

Authors:  Francesca Dall'Ara; Maria-Grazia Lazzaroni; Chiara M Antonioli; Paolo Airò
Journal:  Rheumatol Int       Date:  2017-02-03       Impact factor: 2.631

3.  Systemic Sclerosis-Specific Antibodies: Novel and Classical Biomarkers.

Authors:  Ilaria Cavazzana; Tamara Vojinovic; Paolo Airo'; Micaela Fredi; Angela Ceribelli; Eleonora Pedretti; Maria Grazia Lazzaroni; Emirena Garrafa; Franco Franceschini
Journal:  Clin Rev Allergy Immunol       Date:  2022-06-18       Impact factor: 8.667

Review 4.  Risk of rheumatic disease in breast implant users: a qualitative systematic review.

Authors:  Sabrina Hoa; Kathleen Milord; Marie Hudson; Stephen C Nicolaidis; Josiane Bourré-Tessier
Journal:  Gland Surg       Date:  2021-08

Review 5.  A Narrative Review of Pathogenetic and Histopathologic Aspects, Epidemiology, Classification Systems, and Disease Outcome Measures in Systemic Sclerosis.

Authors:  Maria-Grazia Lazzaroni; Silvia Piantoni; Fabrizio Angeli; Stefania Bertocchi; Franco Franceschini; Paolo Airò
Journal:  Clin Rev Allergy Immunol       Date:  2022-03-07       Impact factor: 10.817

Review 6.  Breast Implant-Associated Immunological Disorders.

Authors:  Lily J Suh; Imran Khan; Christine Kelley-Patteson; Ganesh Mohan; Aladdin H Hassanein; Mithun Sinha
Journal:  J Immunol Res       Date:  2022-05-04       Impact factor: 4.493

Review 7.  Classical Disease-Specific Autoantibodies in Systemic Sclerosis: Clinical Features, Gene Susceptibility, and Disease Stratification.

Authors:  Changyi Yang; Shunli Tang; Dingxian Zhu; Yingguo Ding; Jianjun Qiao
Journal:  Front Med (Lausanne)       Date:  2020-11-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.